Full text
Earnings transcript
Read the complete earnings call transcript.
PUK
Prudential plc
$27.71
-0.6
(-2.1%)
| Exchange: | NYSE |
| Market Cap: | 34.47B |
| Shares Outstanding: | 0 |
Delayed data
About The Company
| Sector: | Financial Services | |||||
| Industry: | Insurance – Life | |||||
| CEO: | Anil Wadhwani | |||||
| Full Time Employees: | 15338 | |||||
| Address: |
| |||||
| Website: | https://www.prudentialplc.com |
Prudential plc, operating through its various subsidiaries, delivers a diverse array of financial solutions to individuals across Asia and Africa, encompassing life and health coverage, retirement planning, and comprehensive asset management services. Its product portfolio includes extensive health and protection plans, along with various savings instruments such as participating, unit-linked, and conventional policies. The company additionally offers insurance against widespread critical illnesses like cancer, strokes, and heart attacks, and provides specialized protection for tropical diseases such as dengue, malaria, and measles. Furthermore, Prudential plc manages a broad spectrum of investment portfolios for both institutional clients and private individuals, utilizing strategies that span equities, fixed income, multi-asset approaches, quantitative methods, and alternative investments. These products and services are made available through its dedicated agency network, banking collaborators, and independent brokers. Founded in 1848, the firm’s primary operations are based in London, United Kingdom.
Click to read more…
Revenue Segmentation
EPS
Historical EPS and analyst estimates in one chart. Log in for the full interactive view and links to detailed estimates.
Earnings Call
AI summary
Key takeaways
Short, structured highlights from the call so you can focus on what matters.
Log in to continue
Log in to read the full transcript and AI-generated earnings summaries.
Login — it's freeIncome Statement
| Year | 2023 | 2024 | 2025 |
|---|---|---|---|
| Revenue | 11,970,000 | 8,139,000 | 27,781,078 |
| Gross Profit | 11,970,000 | 8,139,000 | 27,781,078 |
| EBITDA | 3,059,000 | 3,124,000 | 5,128,815 |
| Operating Income | 2,097,000 | 2,953,000 | 4,945,643 |
| Net Income | 1,701,000 | 2,285,000 | 3,981,738 |
(* All numbers are in thousands)
Balance Sheet
| Year | 2023 | 2024 | 2025 |
|---|---|---|---|
| Total Assets | 174,066,000 | 181,876,000 | 157,482,641 |
| Total Liabilities | 156,083,000 | 163,202,000 | 141,630,104 |
| Total Stockholders Equity | 17,823,000 | 17,492,000 | 14,930,033 |
| Total Debt | 4,874,000 | 4,722,000 | 4,478,936 |
| Cash and Cash Equivalents | 1,590,000 | 2,445,000 | 5,719,085 |
(* All numbers are in thousands)
Cash Flow Statement
| Year | 2023 | 2024 | 2025 |
|---|---|---|---|
| Operating Cash Flow | 644,000 | 3,609,000 | 1,691,615.710 |
| Capital Expenditure | -44,000 | -101,000 | -77,365.009 |
| Free Cash Flow | 600,000 | 3,508,000 | 1,614,250.700 |
| Net Income | 1,701,000 | 3,239,000 | 2,959,211.652 |
| Net Change in Cash | -763,000 | 1,021,000 | 1,435,337.440 |
(* All numbers are in thousands)
Analyst Estimates
| Fiscal Year | 2030 | Research Access | Research Access | Research Access | Research Access |
|---|---|---|---|---|---|
| Estimated Revenue (Low) | 36,240,445.597 | Research Access | Research Access | Research Access | Research Access |
| Estimated Revenue (High) | 58,145,304.938 | Research Access | Research Access | Research Access | Research Access |
| Estimated Revenue (Avg) | 43,661,315.813 | Research Access | Research Access | Research Access | Research Access |
| Estimated Ebitda (Low) | 6,529,887.407 | Research Access | Research Access | Research Access | Research Access |
| Estimated Ebitda (High) | 10,476,755.686 | Research Access | Research Access | Research Access | Research Access |
| Estimated Ebitda (Avg) | 7,866,996.986 | Research Access | Research Access | Research Access | Research Access |
| Estimated Net Income (Low) | 3,959,577.603 | Research Access | Research Access | Research Access | Research Access |
| Estimated Net Income (High) | 7,274,503.505 | Research Access | Research Access | Research Access | Research Access |
| Estimated Net Income (Avg) | 5,082,600.003 | Research Access | Research Access | Research Access | Research Access |
| Estimated SGA Expense (Low) | 3,424,441.011 | Research Access | Research Access | Research Access | Research Access |
| Estimated SGA Expense (High) | 5,494,280.315 | Research Access | Research Access | Research Access | Research Access |
| Estimated SGA Expense (Avg) | 4,125,655.687 | Research Access | Research Access | Research Access | Research Access |
| Estimated EPS (Avg) | 3.940 | Research Access | Research Access | Research Access | Research Access |
| Estimated EPS (High) | 5.640 | Research Access | Research Access | Research Access | Research Access |
| Estimated EPS (Low) | 3.070 | Research Access | Research Access | Research Access | Research Access |
| Number of Analysts (Estimated Revenue) | 1 | Research Access | Research Access | Research Access | Research Access |
| Number of Analysts (Estimated EPS) | 1 | Research Access | Research Access | Research Access | Research Access |
Log in to continue
Log in and subscribe to Full Access to see up to 5 years of analyst estimates.
Login — it's free(* All numbers are in thousands)
Current Key Metrics
Log in to continue
Log in to see all key valuation metrics and ratios for this symbol.
Login — it's freeForward P/E Ratios
Log in to continue
Log in with Full Access for forward P/E high/low estimates and the full multi-year table.
Login — it's freeSWOT Analysis
Strengths (preview)
- Solid New Business Profit Growth: Prudential reported an 8% growth in new business profit (NBP) for the first half of 2024, as highlighted in the earnings call transcript. This indicates strong performance in core markets and effective execution of growth strategies.
- Operational Efficiency Initiatives: The company is focusing on operational efficiency through strategic initiatives and technology investments, as noted in the earnings call summary. This positions Prudential to reduce costs and improve margins over time.
- Disciplined Capital Management: Prudential's emphasis on disciplined capital allocation, as mentioned in the earnings call, supports enhanced shareholder returns through potential dividend stability or share buybacks, reflecting financial prudence.
- Strong Revenue Base: Historical income statement data shows consistent revenue generation, providing a stable foundation for sustained operations and investment in growth areas.
Log in with Research Access for Weaknesses, Opportunities, Threats, and the complete SWOT.
At what price to buy it? -
Intrinsic Value Calculator
This is an automatic estimate. The most reliable way to know fair value for your own assumptions is to run the calculator below.
[intrinsic_calculator]
Common questions about PUK valuation
Is Prudential plc (PUK) overvalued or undervalued right now?
MARKETSnap estimates intrinsic value for Prudential plc (PUK) using its proprietary valuation methodology, which incorporates discounted cash flow (DCF) analysis together with long-term earnings and fundamentals assumptions. By comparing intrinsic value to the current market price, long-term investors can see whether the stock screens as potentially overvalued, fairly valued, or undervalued today.
Is PUK a buy, hold, or sell for long-term investors?
MARKETSnap does not give one-word “buy” or “sell” calls. Instead, it shows whether PUK trades at a premium or discount to its estimated intrinsic value, how sensitive that value is to growth and margin assumptions, and how the stock fits into a diversified, long-term portfolio so investors can make their own buy, hold, or sell decision.
What is PUK’s P/E ratio?
You can see PUK’s trailing P/E (TTM) and forward P/E estimates in the Current Key Metrics and Forward P/E Ratios sections above. The P/E ratio compares the current share price to earnings per share and helps investors gauge valuation relative to earnings.
How is intrinsic value calculated for PUK?
MARKETSnap uses its own valuation framework—not a generic spreadsheet DCF alone. Future cash flows and earnings are projected, discounted, and combined with MARKETSnap’s methodology so intrinsic value reflects fundamentals and long-term assumptions. You can run your own inputs and see the result using the Intrinsic Value Calculator above.
Is PUK a good long-term investment?
Whether PUK fits a long-term portfolio depends on your assumptions about growth, margins, and risk. MARKETSnap provides the metrics, intrinsic value calculator, and SWOT context so you can form your own view rather than rely on a single buy/sell rating.
PUK
1-day price chart preview. Log in for 1W through 5Y ranges and period tabs.
Daily snapshot
-2.1
Trading Metrics:
| Open: | 27.98 | Previous Close: | 28.3 | |
| Day Low: | 27.42 | Day High: | 28.18 | |
| Year Low: | 24.61 | Year High: | 34.03 | |
| Price Avg 50: | 28.12 | Price Avg 200: | 29.58 | |
| Volume: | 1.585M | Average Volume: | 1.072M |
Log in to continue
Log in for multi-period charts (1W–5Y), period tabs, and the same layout as members.
Login — it's freePUK full analysis
Hey everyone, welcome back to the channel! Today, we’re diving deep into a comprehensive analysis of Prudential plc, ticker symbol PUK, a major player in the global insurance and financial services space. If you’re looking to understand whether this stock deserves a spot in your portfolio, stick around because we’re covering everything from financials to recent performance and long-term potential. Let’s get started! So, first off, let’s set the stage. Prudential plc is a well-established name, and I’m excited to…
